BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 22065586)

  • 21. The transcription factor NFAT1 induces apoptosis through cooperation with Ras/Raf/MEK/ERK pathway and upregulation of TNF-α expression.
    Robbs BK; Lucena PI; Viola JP
    Biochim Biophys Acta; 2013 Aug; 1833(8):2016-28. PubMed ID: 23583303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation.
    Nazarian R; Shi H; Wang Q; Kong X; Koya RC; Lee H; Chen Z; Lee MK; Attar N; Sazegar H; Chodon T; Nelson SF; McArthur G; Sosman JA; Ribas A; Lo RS
    Nature; 2010 Dec; 468(7326):973-7. PubMed ID: 21107323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional interactions of Raf and MEK with Jun-N-terminal kinase (JNK) result in a positive feedback loop on the oncogenic Ras signaling pathway.
    Adler V; Qu Y; Smith SJ; Izotova L; Pestka S; Kung HF; Lin M; Friedman FK; Chie L; Chung D; Boutjdir M; Pincus MR
    Biochemistry; 2005 Aug; 44(32):10784-95. PubMed ID: 16086581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recruitment and activation of Raf-1 kinase by nitric oxide-activated Ras.
    Deora AA; Hajjar DP; Lander HM
    Biochemistry; 2000 Aug; 39(32):9901-8. PubMed ID: 10933809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
    Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
    Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rit contributes to nerve growth factor-induced neuronal differentiation via activation of B-Raf-extracellular signal-regulated kinase and p38 mitogen-activated protein kinase cascades.
    Shi GX; Andres DA
    Mol Cell Biol; 2005 Jan; 25(2):830-46. PubMed ID: 15632082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reactivation of mitogen-activated protein kinase (MAPK) pathway by FGF receptor 3 (FGFR3)/Ras mediates resistance to vemurafenib in human B-RAF V600E mutant melanoma.
    Yadav V; Zhang X; Liu J; Estrem S; Li S; Gong XQ; Buchanan S; Henry JR; Starling JJ; Peng SB
    J Biol Chem; 2012 Aug; 287(33):28087-98. PubMed ID: 22730329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stimulation of B-Raf increases c-Jun and c-Fos expression and upregulates AP-1-regulated gene transcription in insulinoma cells.
    Langfermann DS; Rössler OG; Thiel G
    Mol Cell Endocrinol; 2018 Sep; 472():126-139. PubMed ID: 29225069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tanshinone IIA Facilitates TRAIL Sensitization by Up-regulating DR5 through the ROS-JNK-CHOP Signaling Axis in Human Ovarian Carcinoma Cell Lines.
    Chang CC; Kuan CP; Lin JY; Lai JS; Ho TF
    Chem Res Toxicol; 2015 Aug; 28(8):1574-83. PubMed ID: 26203587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C-Raf is required for the initiation of lung cancer by K-Ras(G12D).
    Karreth FA; Frese KK; DeNicola GM; Baccarini M; Tuveson DA
    Cancer Discov; 2011 Jul; 1(2):128-36. PubMed ID: 22043453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of PTEN expression is essential for antiapoptosis and cellular transformation by oncogenic Ras.
    Vasudevan KM; Burikhanov R; Goswami A; Rangnekar VM
    Cancer Res; 2007 Nov; 67(21):10343-50. PubMed ID: 17974977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ERK/pERK expression and B-raf mutations in colon adenocarcinomas: correlation with clinicopathological characteristics.
    Levidou G; Saetta AA; Gigelou F; Karlou M; Papanastasiou P; Stamatelli A; Kavantzas N; Michalopoulos NV; Agrogiannis G; Patsouris E; Korkolopoulou P
    World J Surg Oncol; 2012 Feb; 10():47. PubMed ID: 22376079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ERK mediated upregulation of death receptor 5 overcomes the lack of p53 functionality in the diaminothiazole DAT1 induced apoptosis in colon cancer models: efficiency of DAT1 in Ras-Raf mutated cells.
    Thamkachy R; Kumar R; Rajasekharan KN; Sengupta S
    Mol Cancer; 2016 Mar; 15():22. PubMed ID: 26956619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radicicol suppresses transformation and restores tropomyosin-2 expression in both ras- and MEK-transformed cells without inhibiting the Raf/MEK/ERK signaling cascade.
    Kim PN; Jonasch E; Mosterman BC; Mier JW; Janssen RA
    Cell Growth Differ; 2001 Nov; 12(11):543-50. PubMed ID: 11714635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The BRAF(V600E) inhibitor, PLX4032, increases type I collagen synthesis in melanoma cells.
    Jenkins MH; Croteau W; Mullins DW; Brinckerhoff CE
    Matrix Biol; 2015 Oct; 48():66-77. PubMed ID: 25989506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transformation by oncogenic RAS sensitizes human colon cells to TRAIL-induced apoptosis by up-regulating death receptor 4 and death receptor 5 through a MEK-dependent pathway.
    Drosopoulos KG; Roberts ML; Cermak L; Sasazuki T; Shirasawa S; Andera L; Pintzas A
    J Biol Chem; 2005 Jun; 280(24):22856-67. PubMed ID: 15757891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tocotrienols induce apoptosis in breast cancer cell lines via an endoplasmic reticulum stress-dependent increase in extrinsic death receptor signaling.
    Park SK; Sanders BG; Kline K
    Breast Cancer Res Treat; 2010 Nov; 124(2):361-75. PubMed ID: 20157774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of de novo ceramide synthesis in gamma-tocopherol and gamma-tocotrienol-induced apoptosis in human breast cancer cells.
    Gopalan A; Yu W; Jiang Q; Jang Y; Sanders BG; Kline K
    Mol Nutr Food Res; 2012 Dec; 56(12):1803-11. PubMed ID: 23065795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Langerhans cell histiocytosis: A neoplastic disorder driven by Ras-ERK pathway mutations.
    Tran G; Huynh TN; Paller AS
    J Am Acad Dermatol; 2018 Mar; 78(3):579-590.e4. PubMed ID: 29107340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upregulation of DR5 by proteasome inhibitors potently sensitizes glioma cells to TRAIL-induced apoptosis.
    Hetschko H; Voss V; Seifert V; Prehn JH; Kögel D
    FEBS J; 2008 Apr; 275(8):1925-36. PubMed ID: 18341587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.